Middle East Journal of Cancer (MEJC) is an international peer-reviewed journal which aims to publish high-quality basic science and clinical research in the field of cancer. This journal will also reflect the current status of research as well as diagnostic and treatment practices in the field of cancer in the Middle East, where cancer is becoming a growing health problem. Lastly, MEJC would like to become a model for regional journals with an international outlook. Accordingly, manuscripts from authors anywhere in the world will be considered for publication. From June 1, 2020, the payment of a processing and publication charges are mandatory (for Iranian authors) for all types of manuscripts sent to the Middle East Journal of Cancer (MEJC).
MEJC is indexed in the Thomson Reuters Web of Science: Emerging Sources Citation Index (ESCI), a new edition of Web of Science™. All articles starting from 2015, will be included in this index.
Middle East Journal of Cancer has now received an impact factor of 0.4
Pages 20-29
Pages 30-42
Pages 43-54
Pages 55-62
Pages 63-67
Pages 68-71
Pages 72-77
Pages 78-78
Volume 8, Issue 4, October 2017, Pages 223-228
Volume 9, Issue 4, October 2018, Pages 339-343
Volume 3, Issue 1, January 2012, Pages 9-13
Volume 7, Issue 2, April 2016, Pages 69-78
Volume 3, Issue 4, October 2012, Pages 95-99
Publisher:
Shiraz University of Medical Sciences
Chairperson:
Abdolrasoul Talei, MD
Editor-in-Chief:
Ahmad Mosalaei, MD
Founding Editor:
Farhad Handjani, MD
Associate Editor:
Ahmad Monabati, MD
Seyyed Hasan Hamedi, MD
Editorial Board:
Ehsan Farashahi Yazd
Frequency: Quarterly
Print ISSN: 2008-6709
Online ISSN: 2008-6687